Suppr超能文献

免疫化学粪便潜血试验对小的结直肠腺瘤的敏感性。

Sensitivity of immunochemical fecal occult blood test to small colorectal adenomas.

作者信息

Morikawa Tamiya, Kato Jun, Yamaji Yutaka, Wada Ryoichi, Mitsushima Toru, Sakaguchi Kohsaku, Shiratori Yasushi

机构信息

Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.

出版信息

Am J Gastroenterol. 2007 Oct;102(10):2259-64. doi: 10.1111/j.1572-0241.2007.01404.x. Epub 2007 Jul 7.

Abstract

BACKGROUND

Although the immunochemical fecal occult blood test (FOBT) is reportedly more sensitive to large adenomas or colorectal cancer (CRC) than the guaiac-based FOBT, the sensitivity of the immunochemical FOBT to small adenomas has scarcely been reported. Previous reports have indicated that the guaiac-based FOBT can detect small adenomas only by serendipity.

OBJECTIVES

To investigate the sensitivity of immunochemical FOBT to small adenomas using a large-scale cohort.

METHODS

We analyzed 21,805 consecutively enrolled asymptomatic persons who underwent colonoscopy and immunochemical FOBT.

RESULTS

The sensitivity to adenomas </=9 mm was significantly higher than the false-positive rate as revealed by analysis of all eligible subjects (7.0%vs 4.5%, P < 0.001). In men, the sensitivity was superior to the false-positive rate and increased with age (<50 yr 6.1% and >60 yr 11.3%). On the other hand, the sensitivity in women was not significantly different from the false-positive rate in any generation (5.1%vs 4.7% for all eligible women, P= 0.72).

CONCLUSIONS

Immunochemical FOBT detected a small percentage of small adenomas in men at a rate that is significantly higher than the false-positive rate. Studies comparing the guaiac and immunochemical FOBTs using the end point of CRC-related death are expected.

摘要

背景

尽管据报道免疫化学粪便潜血试验(FOBT)对大腺瘤或结直肠癌(CRC)的敏感性高于基于愈创木脂的FOBT,但免疫化学FOBT对小腺瘤的敏感性鲜有报道。既往报告表明,基于愈创木脂的FOBT仅偶然能检测出小腺瘤。

目的

使用大规模队列研究免疫化学FOBT对小腺瘤的敏感性。

方法

我们分析了21805名连续入组的无症状者,这些人接受了结肠镜检查和免疫化学FOBT。

结果

对直径≤9mm腺瘤的敏感性显著高于对所有符合条件受试者分析得出的假阳性率(7.0%对4.5%,P<0.001)。在男性中,敏感性高于假阳性率且随年龄增加(<50岁为6.1%,>60岁为11.3%)。另一方面,女性在各年龄段的敏感性与假阳性率无显著差异(所有符合条件女性中分别为5.1%对4.7%,P=0.72)。

结论

免疫化学FOBT能检测出一小部分男性小腺瘤,其检出率显著高于假阳性率。预计会开展以CRC相关死亡为终点比较愈创木脂法和免疫化学FOBT的研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验